Form 8-K - Current report:
SEC Accession No. 0000950170-25-108900
Filing Date
2025-08-14
Accepted
2025-08-14 16:18:12
Documents
11
Period of Report
2025-08-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K neog-20250814.htm   iXBRL 8-K 51405
2 EX-99.1 neog-ex99_1.htm EX-99.1 7534
  Complete submission text file 0000950170-25-108900.txt   168152

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT neog-20250814.xsd EX-101.SCH 25023
13 EXTRACTED XBRL INSTANCE DOCUMENT neog-20250814_htm.xml XML 4730
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-17988 | Film No.: 251219493
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)